A group of experts from medicine/surgery, regenerative medicine, and entrepreneurs shares their works and insights.
About this Event:
A group of experts from medicine/surgery, regenerative medicine, and entrepreneurs shares their works and insights on how 3D printing and bioprinting is revolutionizing cardiac care.
Date And Time:
Thu, September 26, 2019
6:30 PM – 9:30 PM PDT
McDermott Will & Emery SF Office/Salesforce Building
415 Mission Street Suite 5600
San Francisco, CA 94105
6:30-7:00 PM Networking/Registration
7:00-7:10 PM Sponsor (MWE) and 3DHEALS Intro
7:10-7:20 PM Dr. Shafkat Anwar (UCSF)
7:20-7:25 PM Q&A
7:25-7:35 PM Shannon Walters (Stanford)
7:35-7:40 PM Q&A
7:40-7:50 PM Orquidea (Orchid) Garcia (JNJ)
7:50-7:55 PM Q&A
8:05-8:10 PM Q&A
8:20-8:25 PM Q&A
8:25-8:40 Panel Q&A
8:40- 9:30 PM Networking/Wrap up
Dr. Shafkat Anwar is a pediatric cardiologist with a specialty in non-invasive cardiac imaging, including echocardiography and cardiac magnetic resonance imaging (MRI). Dr. Shafkat Anwar is a pediatric cardiologist with a specialty in non-invasive cardiac imaging, including echocardiography and cardiac magnetic resonance imaging (MRI).
He is the Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). He is a founding member and the inaugural Chair of the Advanced 3D+ Visualization Special Interest Group in the Society for Cardiovascular Magnetic Resonance. He is a consultant at Printerprezz, a medical start-up in Fremont, CA utilizing additive and other advanced manufacturing technologies to develop the next generation of medical devices. At Printerprezz Dr. Anwar serves as the Senior Vice President of Medical Innovations. Dr. Anwar completed his internship and residency in Pediatrics at Children’s National Medical Center, as well as a research fellowship at the National Institutes of Health. He completed fellowships in Pediatric Cardiology and Cardiac Imaging at Cleveland Clinic and Children’s Hospital of Philadelphia. Prior to joining UCSF, Dr. Anwar was Cardiology Director of Cardiac MRI at Washington University in St. Louis, St. Louis Children’s Hospital. At Wash. U. Dr. Anwar co-founded and co-directed the Center for 3D Printing, a multi-disciplinary 3D printing center.
Shannon Walters is an innovation enabler and workflow, optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. Recent innovations are of particular interest to Shannon such as 3D Printing, immersive volumetric visualization, and concise reporting of changes over time.
As a Johnson & Johnson Research Fellow and Lead for 3D Bioprinting and Tissue Regen Technologies, Orquidea (Orchid) Garcia is the technical lead for 3D bioprinting, and related tissue regen technology development. She is responsible for the evaluation and execution of technical strategies and new technologies integration to develop a new class of next-generation healthcare solutions. Orchid works closely with internal business partners, as well as technology, academia and government partners to develop the CoE’s bioprinting capabilities.
Orchid has extensive experience identifying novel technologies through scientific discovery and translating them into patentable, marketable technologies both in industry and academia. Having served as the scientific subject matter expert on numerous initiatives, she brings a keen understanding of world-wide technical, scientific, regulatory and policy issues that face the business.
Previously, Orchid held various positions at J&J in Clinical Affairs and Regulatory Affairs. She received a Bachelor of Science degree in Biochemistry and Cellular Biology from the University of California San Diego; a Master of Science degree in Microbiology from California State University Los Angeles; and a PhD in Medical Biology from the University of Southern California, Keck School of Medicine. She is a Fellow of the California Institute of Regenerative Medicine (CIRM). Orchid is based in Irvine, CA.
A senior executive with a proven track record in commercialization of innovative medical technology, Mike is a results-oriented, decisive leader with a track record of successfully growing new businesses in both startup and growth organizations. Throughout his career, he has gained extensive experience translating highly complex devices and clinical data into successful businesses, both in the US and globally. Mike holds a BS in Engineering Physics and an MEng in Mechanical Engineering from Cornell University, as well as an MBA from Harvard Business School.
Jordan Miller is an Assistant Professor of Bioengineering at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his PhD in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo.
Roger Kuan focuses his practice on intellectual property (IP) procurement/portfolio management, IP transactions and strategic IP counseling for life sciences clients (e.g., research tools, analytical instrumentation/software, medical devices, diagnostics, biomanufacturing systems, etc.) with a focus in emerging technologies such as digital health (e.g., mobile apps, clinical decision support software, digital therapeutics, AI/ML imaging diagnostics, etc.), personalized medicine (e.g., genomic sequencing platforms, AI/ML computational genomics/bioinformatics, molecular diagnostics, etc.) and 3D printing/bioprinting. He has extensive experience in intellectual property strategy and management, preparation and prosecution (utility/design patents, trademarks and trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, IP due diligence, IP risk recognition and mitigation, and dispute resolution. He served as Director IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, Roger worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.
Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS, a company focusing on curating healthcare 3D printing ecosystem. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.